Lipid molecule with radiotherapy sensitization, preparation method of lipid molecule and application of lipid molecule in tumor radiotherapy drugs
A functional and lipid-based technology, applied in the field of tumor radiotherapy drugs, can solve the problems of low effective drug concentration, limited application, neurotoxic side effects, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0073] Synthesis of compound (C16-R)
[0074] Weigh 560mg (3.15mmol) of 2-methyl-5-nitroimidazole-1-ethanol, 1g (3.5mmol) of hexadecanedioic acid and 668mg (3.5mmol) of EDC into a round bottom flask, add 50mLDMSO, add 854mg (7.0mmol) DMAP, react at 40°C for 24h. At the end of the reaction, the solvent was removed using evacuation. Obtain solid using flash chromatography column MeCN:H 2 O was purified at 60-100%. The solvent was removed using a rotary evaporator to obtain 842 mg of a white solid. The yield was 57.4%. 1 HNMR (400MHz, DMSO-d 6 ) 1.24 (CH 2 ,br,20H), 1.33-1.49 (CH 2 -CH 2 -C=O,m,4H),2.15-2.22(CH 2 -C=O,m,4H),2.45(CH 3 -Im,s,3H), 4.36 (CH 2 -Im,t,J=4.2Hz,2H),4.58(CH 2 -CH 2 -Im,t,J=4.2Hz,2H),8.02(Im-H,s,1H),11.94(HO-C=O,br,1H); MS(m / z):[M-H] - calcdforC 23 h 36 N 3 o 6 438.26, found 438.29. (see figure 1 ).
[0075] Synthesis of compound (X-C16-R)
[0076] Take 109mg (0.9mmol) of N,N-dimethyl-3-amino-1,2-propanediol, 842mg (1.9mmol) of compound...
Embodiment 2
[0078] Synthesis of compound (C14-R)
[0079] Weigh 560mg (3.15mmol) of 2-methyl-5-nitroimidazole-1-ethanol, 905mg (3.5mmol) of tetradecanedioic acid and 668mg (3.5mmol) of EDC into a round bottom flask, add 50mLDMSO, add 854mg (7.0mmol) DMAP, react at 40°C for 24h. At the end of the reaction, the solvent was removed using evacuation. Obtain solid using flash chromatography column MeCN:H 2 O was purified at 60-100%. The solvent was removed using a rotary evaporator to obtain 842 mg of a white solid. The yield was 57.4%. 1HNMR (400MHz, CDCl 3 ) 1.25 (CH 2 ,br,16H), 1.55-1.65 (CH 2 CH 2 C(=O)-O,m,4H),2.26(CH 2 C(=O)-OH,t,J=8.0Hz,2H),2.35(CH 2 C(=O)-O,t,J=8.0Hz,2H),2.51(CH 3 -Im,s,3H), 4.42 (Im-CH 2 ,t,J=4.0Hz,2H),4.58(CH 2 -CH 2 -Im,t,J=4.0Hz,2H),7.97(H-Im,s,1H).(see image 3 ).
[0080] Synthesis of compound (X-C14-R)
[0081] Take 132mg (0.9mmol) of 3-diethylamino-1,2-propanediol, 842mg (1.9mmol) of compound (C14-R) and 366mg (1.92mmol) of EDC into a round bot...
Embodiment 3
[0083] Preparation of radiosensitizing liposomes
[0084]Select the ethanol injection method to prepare liposomes, weigh the compound (X-Cn-R) prepared in Example 1 and the auxiliary lipid molecule, the auxiliary lipid molecule is composed of DSPE-PEG2000, DOPC and cholesterol, the lipid The mass fraction of each raw material in the body is: compound (X-Cn-R), 50%; cholesterol 30%; DOPC, 5%; DSPE-PEG2000, 15%; make it fully dissolved in ethanol; The molecules were fully mixed, and liposomes with radiosensitization effects were prepared by ethanol injection method, and the concentration of liposomes was 3 mg / mL.
PUM
| Property | Measurement | Unit |
|---|---|---|
| Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com
